Related references
Note: Only part of the references are listed.Thioredoxin Prevents Loss of UCP2 in Hyperoxia via MKK4-p38 MAPK-PGC1α Signaling and Limits Oxygen Toxicity
Somasundaram Raghavan et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2022)
Cytotoxicity, in silico predictions and molecular studies for androstane heterocycle compounds revealed potential antitumor agent against lung cancer cells
Mohamed A. Tantawy et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)
Colchicine Is Safe Though Ineffective in the Treatment of Severe COVID-19: a Randomized Clinical Trial (COLCHIVID)
Abdiel Absalon-Aguilar et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2022)
CD147-spike protein interaction in COVID-19: Get the ball rolling with a novel receptor and therapeutic target
Tapan Behl et al.
SCIENCE OF THE TOTAL ENVIRONMENT (2022)
Colchicine attenuates renal ischemia-reperfusion-induced liver damage: implication of TLR4/NF-κB, TGF-β, and BAX and Bcl-2 gene expression
Azza Sayed Awad et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2022)
Colchicine-Containing Nanoparticles Attenuates Acute Myocardial Infarction Injury by Inhibiting Inflammation
Li Wang et al.
CARDIOVASCULAR DRUGS AND THERAPY (2022)
Colchicine in Recently Hospitalized Patients with COVID-19: A Randomized Controlled Trial (COL-COVID)
Domingo A. Pascual-Figal et al.
INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2021)
COVID-19: Current understanding of its Pathophysiology, Clinical presentation and Treatment
Anant Parasher
POSTGRADUATE MEDICAL JOURNAL (2021)
Computational selection of flavonoid compounds as inhibitors against SARS-CoV-2 main protease, RNA-dependent RNA polymerase and spike proteins: A molecular docking study
Marimuthu Ragavan Rameshkumar et al.
SAUDI JOURNAL OF BIOLOGICAL SCIENCES (2021)
Anti-inflammatory therapy for COVID-19 infection: the case for colchicine
Aaron Z. Reyes et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
4'-O-Methylbroussochalcone B as a novel tubulin polymerization inhibitor suppressed the proliferation and migration of acute myeloid leukaemia cells
Ziying Liu et al.
BMC CANCER (2021)
The SARS-CoV-2 Spike protein disrupts human cardiac pericytes function through CD147 receptor-mediated signalling: a potential non-infective mechanism of COVID-19 microvascular disease
Elisa Avolio et al.
CLINICAL SCIENCE (2021)
Mechanism of SARS-CoV-2 polymerase stalling by remdesivir
Goran Kokic et al.
NATURE COMMUNICATIONS (2021)
Emerging Anti-Atherosclerotic Therapies
Anna Gluba-Brzozka et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Colchicine, COVID-19 and hematological parameters: A meta-analysis
Musharraf Sarwar et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2021)
Identification of 3-chymotrypsin like protease (3CLPro) inhibitors as potential anti-SARS-CoV-2 agents
Vicky Mody et al.
COMMUNICATIONS BIOLOGY (2021)
Colchicine and SARS-CoV-2: Management of the hyperinflammatory state
Antonio Vitiello et al.
RESPIRATORY MEDICINE (2021)
S-allylcysteine inhibits chondrocyte inflammation to reduce human osteoarthritis via targeting RAGE, TLR4, JNK, and Nrf2 signaling: comparison with colchicine
Zubeyir Elmazoglu et al.
BIOCHEMISTRY AND CELL BIOLOGY (2021)
Colchicine and the heart
Massimo Imazio et al.
EUROPEAN HEART JOURNAL (2021)
PROACTIVE ANTI-INFLAMMATORY THERAPY WITH COLCHICINE IN THE TREATMENT OF ADVANCED STAGES OF NEW CORONAVIRUS INFECTION. THE FIRST RESULTS OF THE COLORIT STUDY
V. Yu. Mareev et al.
KARDIOLOGIYA (2021)
Efficacy and safety of colchicine in COVID-19: a meta-analysis of randomised controlled trials
Kedar Gautambhai Mehta et al.
RMD OPEN (2021)
Reduced mortality in COVID-19 patients treated with colchicine: Results from a retrospective, observational study
Lucio Manenti et al.
PLOS ONE (2021)
Characterization of the SARS-CoV-2 E Protein: Sequence, Structure, Viroporin, and Inhibitors
Yipeng Cao et al.
PROTEIN SCIENCE (2021)
Colchicine for the treatment of COVID-19 patients: efficacy, safety, and model informed dosage regimens
Eleni Karatza et al.
XENOBIOTICA (2021)
Colchicine Blocks Tubulin Heterodimer Recycling by Tubulin Cofactors TBCA, TBCB, and TBCE
Sofia Nolasco et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Immunopathology and Immunopathogenesis of COVID-19, what we know and what we should learn
Mehdi Shahgolzari et al.
GENE REPORTS (2021)
Microtubule inhibitors identified through nonbiased screening enhance DNA transfection efficiency by delaying p62-dependent ubiquitin recruitment
Megumi Tsuchiya et al.
GENES TO CELLS (2021)
The potential role of neopterin in Covid-19: a new perspective
Hayder M. Al-kuraishy et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2021)
Exploring SARS-CoV-2 Spikes Glycoproteins for Designing Potential Antiviral Targets
Noha A. Kamel et al.
VIRAL IMMUNOLOGY (2021)
Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial
Jean-Claude Tardif et al.
LANCET RESPIRATORY MEDICINE (2021)
Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Group Author Only
LANCET RESPIRATORY MEDICINE (2021)
Colchicine acts selectively in the liver to induce hepatokines that inhibit myeloid cell activation
Jui-Hsia Weng et al.
NATURE METABOLISM (2021)
Coronavirus biology and replication: implications for SARS-CoV-2
Philip V'kovski et al.
NATURE REVIEWS MICROBIOLOGY (2021)
Beneficial effects of colchicine for moderate to severe COVID-19: a randomised, double-blinded, placebo-controlled clinical trial
Maria Isabel Lopes et al.
RMD OPEN (2021)
Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment
Mehmet Soy et al.
CLINICAL RHEUMATOLOGY (2020)
What Do We Know About Remdesivir Drug Interactions?
Katherine Yang
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2020)
Colchicine treatment impairs skeletal muscle mitochondrial function and insulin sensitivity in an age-specific manner
Bjorg Thiellesen Buch et al.
FASEB JOURNAL (2020)
The COVID-19 Cytokine Storm; What We Know So Far
Dina Ragab et al.
FRONTIERS IN IMMUNOLOGY (2020)
Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019 The GRECCO-19 Randomized Clinical Trial
Spyridon G. Deftereos et al.
JAMA NETWORK OPEN (2020)
Analysis of SARS-CoV-2 RNA-dependent RNA polymerase as a potential therapeutic drug target using a computational approach
Syed Ovais Aftab et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
NMK-BH2, a novel microtubule-depolymerising bis (indolyl)-hydrazide-hydrazone, induces apoptotic and autophagic cell death in cervical cancer cells by binding to tubulin at colchicine - site
Dipanwita Das Mukherjee et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2020)
A molecular docking study repurposes FDA approved iron oxide nanoparticles to treat and control COVID-19 infection
Yasmin Abo-zeid et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Cytoskeleton-a crucial key in host cell for coronavirus infection
Zeyu Wen et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2020)
Malleability of the SARS-CoV-2 3CL Mpro Active-Site Cavity Facilitates Binding of Clinical Antivirals
Daniel W. Kneller et al.
STRUCTURE (2020)
Potential of natural astaxanthin in alleviating the risk of cytokine storm in COVID-19
Jayanta Talukdar et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
SARS coronavirus 2: from genome to infectome
Meghana Rastogi et al.
RESPIRATORY RESEARCH (2020)
Prediction of potential inhibitors for RNA-dependent RNA polymerase of SARS-CoV-2 using comprehensive drug repurposing and molecular docking approach
Md Sorwer Alam Parvez et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2020)
A Case Control Study to Evaluate the Impact of Colchicine on Patients Admitted to the Hospital with Moderate to Severe COVID-19 Infection
Tegveer Sandhu et al.
CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY (2020)
Adverse events during oral colchicine use: a systematic review and meta-analysis of randomised controlled trials
Sarah Stewart et al.
ARTHRITIS RESEARCH & THERAPY (2020)
How COVID-19 induces cytokine storm with high mortality
Shintaro Hojyo et al.
INFLAMMATION AND REGENERATION (2020)
Severe Acute Respiratory Syndrome Coronavirus Viroporin 3a Activates the NLRP3 Inflammasome
I-Yin Chen et al.
FRONTIERS IN MICROBIOLOGY (2019)
The NLRP3 inflammasome: molecular activation and regulation to therapeutics
Karen V. Swanson et al.
NATURE REVIEWS IMMUNOLOGY (2019)
Colchicine: an ancient drug with novel applications
B. Dasgeb et al.
BRITISH JOURNAL OF DERMATOLOGY (2018)
Platelet-neutrophil interactions as drivers of inflammatory and thrombotic disease
Ton Lisman
CELL AND TISSUE RESEARCH (2018)
Microtubule Regulation and Function during Virus Infection
Mojgan H. Naghavi et al.
JOURNAL OF VIROLOGY (2017)
Colchicine attenuates renal fibrosis in a murine unilateral ureteral obstruction model
Seiji Itano et al.
MOLECULAR MEDICINE REPORTS (2017)
Colchicine-Update on mechanisms of action and therapeutic uses
Ying Ying Leung et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2015)
Genetic drift of human coronavirus OC43 spike gene during adaptive evolution
Lili Ren et al.
SCIENTIFIC REPORTS (2015)
Benefit of combined therapy with nicorandil and colchicine in preventing monocrotaline-induced rat pulmonary arterial hypertension
Fan-Yen Lee et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Colchicine poisoning: the dark side of an ancient drug
Yaron Finkelstein et al.
CLINICAL TOXICOLOGY (2010)
Signal Transducer and Activator of Transcription-3, Inflammation, and Cancer How Intimate Is the Relationship?
Bharat B. Aggarwal et al.
NATURAL COMPOUNDS AND THEIR ROLE IN APOPTOTIC CELL SIGNALING PATHWAYS (2009)
Colchicine: Its mechanism of action and efficacy in crystal-induced inflammation
George Nuki
Current Rheumatology Reports (2008)
Computational modelling of the receptor-tyrosine-kinase-activated MAPK pathway
RJ Orton et al.
BIOCHEMICAL JOURNAL (2005)